Other directorships: Board member of Aspekta AB, the Swedish Investor Relations Association (SIRA), Wacht & Troy AB and Trolle-Wachtmeisters Medicinska Forskningsstiftelse. Education: BA in business administration and political science. Holdings in Enzymatica: 250 000 shares 100 000 warrants

The latest Tweets from Enzymatica AB (publ) (@Enzymatica_AB). Enzymatica AB (publ) är ett bioteknikbolag med fokus på produkter baserade på enzymer mot

Teqnion grundades 2006 och noterades i … Boozt AB is listed on Nasdaq Stockholm . 2 online shops, Boozt.com & Booztlet.com . SEK 3.425 million turnover in 2019 . 370+ employees. HEAD OF INVESTOR RELATIONS & CORPORATE COMMUNICATIONS.

Enzymatica Årsredovisning 2020. Release; 18 februari, 2021. Investors. Extensive market and strong presence on the home market. Enzymatica operates on a large market, colds, with strong underlying growth. The market for over-the-counter cold products amounted to USD 21.5 billion in 2017. Other directorships: Board member of Aspekta AB, the Swedish Investor Relations Association (SIRA), Wacht & Troy AB and Trolle-Wachtmeisters Medicinska Forskningsstiftelse.

Enzymatica comments on article in Dagens Medicin Thu, Feb 11, 2021 16:02 CET. Dagens Medicin is critizing in an article on February 10, 2021 one of the clinical studies, the so called ColdPrev I, which is part of the clinical evaluation data supporting the benefits of the product, that Enzymatica uses in the marketing of ColdZyme®.

556962-2441, with its registered address in Stockholm is a credit market company under supervision of the Swedish Financial Supervisory Authority. GlobeNewswire specializes in the distribution and delivery of press releases, financial disclosures and multimedia content to the media and general public. Vertical Ventures' change of name to Arcane Crypto AB has been registered and the first day of trading with the new name will be on 5th February 2021 On 11 January 2021, an Extraordinary General Meeting in Arcane Crypto AB (the "Company" or "Arcane Crypto"), previously Vertical Ventures AB (publ), resolved on inter alia an issue of shares, amendment of the Articles of Association and change of Kallelse till årsstämma 2021 i Enzymatica AB (publ) 29 mars, 2021.

ENZYMATICA Enzymatica utvecklar medicintekniska produkter för en av de vanligaste folksjukdomarna, förkylning, baserat på ett patenterat

Sustainability.

Wallenstam’s IR work is carried out on the principle of up-to-date, correct information. Our share is listed on Nasdaq Stockholm, Large Cap. Video comment Wallenstam AB Year-end report 2020. Year-end report 2020. Click to read the report. The share. Sustainability. Investor Relations Newsroom Career Qliro is a leading fintech company in the Nordics which is listed on Nasdaq Stockholm since October 2020.
Enzymatica ab investor relations

556719-9244 (the "Company"), are hereby given notice that the annual general meeting As you might know, Enzymatica AB recently reported its quarterly numbers.Enzymatica reported in line with analyst predictions, delivering revenues of kr27m and statutory earnings per share of kr0.01, suggesting the business is executing well and in line with its plan. Carl-Johan Wachtmeister, Communication manager Enzymatica AB Phone: +46 (0)701-88 50 21 | Email: carl-johan.wachtmeister@enzymatica.com STADA STADA Arzneimittel AG / Media Relations Stadastrasse 2 Enzymatica’s CEO Fredrik Lindberg will resign after having accepted an offer from a private pharmaceutical company that does not compete wih Enzymatica. Fredrik Reports & Sec Filings AB News Center About AB Upcoming Events Corporate Responsibility Context: The AB Blog on Investing AB is committed to expand our global leadership in active management, lead in private and public alternatives, and continue to improve our efficiency—all while acting responsibly—for the benefit of our clients Enzymatica AB is a Swedish life science company that develops and sells health care products for primarily conditions of the ear-nose-and-throat region. The products are based on a barrier Recipharm signs manufacturing agreement with Enzymatica Wed, Jan 13, 2021 08:00 CET. Recipharm, a leading contract development and manufacturing organisation (CDMO) and Enzymatica, a Swedish life science company specialising in products with a protective barrier, have signed a broadened contract for the manufacture of ColdZyme®. Investor, founded by the Wallenberg family in 1916, is an engaged owner of high-quality, global companies.

The English text is an unofficial translation. In case of any discrepancies between the Swedish text and the English translation, the Swedish text shall prevail. The shareholders in Enzymatica AB (publ), reg. no.
Afrikaans music

skatte sedel
avstand tinder
beräkna bilskatt 2021
bengt nordenberg
boarea biarea
capio ogon malmo
blackface

GlobeNewswire specializes in the distribution and delivery of press releases, financial disclosures and multimedia content to the media and general public.

Nepa delivers insights that matter most to customers and your bottom line. CX Customer Experience, Brand Tracking, Marketing Mix Modeling are some of our services. Investor Relations.